Mr. Kevin Ali, President, Emerging Markets, MSD was presented the Genome Valley Excellence Award - 2012 by Hon’ble Chief Minister N.Kiran Kumar Reddy, who formally inaugurated the 9th edition of BioAsia 2012, at Hyderabad. The award ceremony was attended by members of the global biotech fraternity and other dignitaries.
While discussing MSD's commitment to research and the significance of the award, Mr. Ali, said, "It is an honour to accept the Genome Valley Excellence Award on behalf of MSD. We are proud that the State of Andhra Pradesh has recognized our commitment to cutting edge research and leadership status in the biopharmaceutical space, particularly vaccines. The award encourages us to continue developing better vaccines for the world's major infectious diseases, to innovate, and to work hard to find ways to make our products even more accessible to those who need them."
Instituted in 2004 by the Government of Andhra Pradesh, the Genome Valley Excellence Award recognizes and honours eminent individuals and organizations for their exceptional contribution to Life Sciences research & development and encourages path-breaking innovations and achievements. Since then it has been continued in every edition of BioAsia. The Awards reflect BioAsia 2012's commitment to enabling the proliferation of ideas and discoveries intended to elevate the quality of human life itself.
About MSD India:
MSD operates its human health business in India through three separate legal entities: MSD Pharmaceuticals Pvt. Ltd., Organon India Limited and Fulford India Limited, which are subsidiaries of Merck & Co. Inc., Whitehouse Station, N.J., USA. Since its existence in India, the company has moved quickly in laying the foundation for a business that is differentiated by its focus on launching innovative products relevant to India. MSD in India currently operates in various therapeutic areas including Metabolics, Cardiovascular, Vaccines, Critical Care, Immunology, Virology, Oncology, Women's Health, Dermatology, Respiratory, Virology, Musculoskeletal and Primary Care and offers a strong and diversified product portfolio of over 75 brands, of which 13 are already category leading products.
For more information, please visit: www.merck.com / www.msd.in
Sourced From: Corporate Voice | Weber Shandwick
